BioNTech SE
BNTX
$96.51
-$0.22-0.23%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.55M | -438.76M | -437.57M | 276.62M | 217.79M |
| Total Depreciation and Amortization | 145.20M | 57.88M | 45.04M | 176.31M | 48.81M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.17M | -62.31M | 9.26M | -208.82M | -226.58M |
| Change in Net Operating Assets | 752.91M | 609.46M | -438.30M | -737.97M | -742.41M |
| Cash from Operations | 912.73M | 166.27M | -821.57M | -493.86M | -702.39M |
| Capital Expenditure | -41.97M | -30.76M | -51.46M | -70.99M | -80.03M |
| Sale of Property, Plant, and Equipment | 3.39M | 567.50K | 526.20K | 746.20K | 329.80K |
| Cash Acquisitions | -- | -- | -82.61M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.04B | -42.90M | 1.45B | 716.97M | -76.52M |
| Cash from Investing | -1.08B | -73.09M | 1.31B | 646.72M | -156.22M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.50M | -13.30M | -13.80M | -7.30M | -7.90M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -13.44M | -15.09M | -14.52M | -7.78M | -8.69M |
| Foreign Exchange rate Adjustments | -25.14M | 10.44M | -16.94M | 14.50M | -2.53M |
| Miscellaneous Cash Flow Adjustments | 1.17M | 7.49M | -13.89M | -13.22M | 42.99M |
| Net Change in Cash | -206.47M | 96.02M | 445.14M | 146.36M | -826.84M |